DILATATION INTRAHEPATIC DUCT ACQUIRED side effect
What is DILATATION INTRAHEPATIC DUCT ACQUIRED ?Drugs associated with DILATATION INTRAHEPATIC DUCT ACQUIRED
ACYCLOVIR CANCIDAS KETALAR NOVORAPID OMEPRAZOLE ONDANSETRON REVLIMID TAZOCINDILATATION INTRAHEPATIC DUCT ACQUIRED : Acyclovir Side Effects Report #5536651-0
Health Professional from UNITED KINGDOM reported ACYCLOVIR problem on Nov 19, 2007. Female patient, 19 years of age, was diagnosed with pain and was treated with ACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease, . ACYCLOVIR dosage: unknown. During the same period patient was treated with ALLOPURINOL, CASPOFUNGIN, CHLORPHENAMINE, CYCLOSPORINE, ETOPOSIDE, KETALAR, MORPHINE, NORETHISTERONE. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Acyclovir Side Effects Report #5538256-4
ACYCLOVIR problem was reported by a Health Professional from UNITED KINGDOM on Nov 19, 2007. Female patient, 19 years of age, was diagnosed with pain and was treated with ACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatotoxicity, venoocclusive liver disease, . ACYCLOVIR dosage: unknown. During the same period patient was treated with CYCLOSPORINE, ETOPOSIDE, KETALAR, MORPHINE, NORETHISTERONE, OMEPRAZOLE, ONDANSETRON, ACETAMINOPHEN. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Ketalar Side Effects Report #5573813-0
Pharmacist from UNITED KINGDOM reported KETALAR problem on Dec 14, 2007. Female patient, weighting 136.7 lb, was diagnosed with pain and was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease, . KETALAR dosage: TEXT:4 MG/ML-FREQ:1-6 ML/HOUR INFUSION. During the same period patient was treated with NORETHISTERONELET, VORICONAZOLE, PARACETAMOL, CASPOFUNGIN, CYCLOSPORINE, ONDANSETRON, CHLORPHENAMINE, OMEPRAZOLE. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Ketalar Side Effects Report #5505561-7
KETALAR problem was reported by a Pharmacist from UNITED KINGDOM on Oct 23, 2007. Female patient, weighting 136.7 lb, was diagnosed with pain and was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease, . KETALAR dosage: TEXT:4 MG/ML-FREQ:1-6 ML/HOUR INFUSION. During the same period patient was treated with NORETHISTERONELET, VORICONAZOLE, ACETAMINOPHEN, CASPOFUNGIN, CYCLOSPORINE, ONDANSETRON, CHLORPHENIRAMINE MALEATE, OMEPRAZOLE. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Ondansetron Side Effects Report #5520886-7
Consumer or non-health professional from UNITED KINGDOM reported ONDANSETRON problem on Nov 16, 2007. Female patient, 19 years of age, was treated with ONDANSETRON. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatic enzyme increased, hepatotoxicity, venoocclusive disease, . ONDANSETRON dosage: 24MG PER DAY. During the same period patient was treated with PARACETAMOL, ACYCLOVIR, ALLOPURINOL, MORPHINE, CHLORPHENIRAMINE MALEATE, NORETHINDRONE ACETATE, CYCLOSPORINE, CASPOFUNGIN. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Omeprazole Side Effects Report #5525899-7
OMEPRAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2007. Female patient, 19 years of age, was diagnosed with pain and was treated with OMEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease, . OMEPRAZOLE dosage: unknown. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, CASPOFUNGIN, CHLORPHENIRAMINE MALEATE, CYCLOSPORINE, ETOPOSIDE, KETALAR, MORPHINE. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Cancidas Side Effects Report #5526075-4
Health Professional from UNITED KINGDOM reported CANCIDAS problem on Nov 16, 2007. Female patient, 19 years of age, was diagnosed with pain and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease, . CANCIDAS dosage: unknown. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, CHLORPHENIRAMINE MALEATE, CYCLOSPORINE, ETOPOSIDE, KETALAR, MORPHINE, NORETHINDRONE. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Novorapid Side Effects Report #5379938-7
NOVORAPID problem was reported by a Physician from JAPAN on June 28, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatic function abnormal, hepatitis, malaise, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Novorapid Side Effects Report #5389949-3
Physician from JAPAN reported NOVORAPID problem on July 06, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatic function abnormal, hepatitis, malaise, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Novorapid Side Effects Report #5379938-7
NOVORAPID problem was reported by a Physician from JAPAN on June 28, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatic function abnormal, hepatitis, malaise, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Novorapid Side Effects Report #5389949-3
Physician from JAPAN reported NOVORAPID problem on July 06, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dilatation intrahepatic duct acquired, hepatic function abnormal, hepatitis, malaise, . NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Revlimid Side Effects Report #5455400-8
REVLIMID problem was reported by a Physician from FRANCE on Sept 07, 2007. Female patient, 77 years of age, weighting 114.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: asthenia, dilatation intrahepatic duct acquired, dyspnoea, jaundice, pain, . REVLIMID dosage: 25 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.
DILATATION INTRAHEPATIC DUCT ACQUIRED : Tazocin Side Effects Report #5526538-1
Health Professional from UNITED KINGDOM reported TAZOCIN problem on Nov 16, 2007. Female patient, 19 years of age, was diagnosed with pain and was treated with TAZOCIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood bilirubin increased, dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease, . TAZOCIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, CASPOFUNGIN ACETATE, CHLORPHENAMINE, CYCLOSPORINE, VORICONAZOLE, KETALAR, MORPHINE, NORETHISTERONE. Patient recovered.